Print Page  |  Close Window

SEC Filings

8-K
MEDPACE HOLDINGS, INC. filed this Form 8-K on 12/08/2016
Entire Document
 

(xii)transaction fees and expenses incurred, or amortization thereof, in connection with, to the extent permitted hereunder, any Investment, any Debt Issuance, any Equity Issuance, any Disposition, any Casualty Event,

recapitalization or any amendments or waivers of the Loan Documents and Permitted Refinancings in connection therewith, in each case, whether or not consummated,

$_____

(xiii)proceeds from business interruption insurance (to the extent not reflected as revenue or income in Consolidated Net Income and to the extent that the related loss was deducted in the determination of Consolidated Net Income),

$_____

(xiv)charges, losses, lost profits, expenses or write-offs to the extent indemnified or insured by a third party, including expenses covered by indemnification provisions in connection with a Permitted Acquisition or any other acquisition permitted by Section 7.02 of the Credit Agreement or any transaction permitted by Section 7.04 or 7.05 of the Credit Agreement, in each case, to the extent that coverage has not been denied and so long as such amounts are actually reimbursed to a member of the Restricted Group in cash within one year after the related amount is first added to Consolidated EBITDA pursuant to this clause (xiv) (and if not so reimbursed within one year, such amount shall be deducted from Consolidated EBITDA during the next measurement period),

$_____

(xv)Synthetic Lease Obligations, to the extent deducted as an expense in such period,

$_____

(xvi)any losses realized upon a Disposition of property outside of the ordinary course of business,

$_____

(xvii)cash receipts (or any netting arrangements resulting in reduced cash expenses) not included in Consolidated EBITDA in any period to the extent non-cash gains relating to such receipts were deducted in the calculation of Consolidated EBITDA pursuant to item I.A.3 below for any previous period and not added back,

$_____

(xviii)net realized losses relating to amounts denominated in foreign currencies resulting from the application of FASB ASC 830 (including net realized losses from exchange rate fluctuations on intercompany balances and balance sheet items, net of realized gains from related Swap Contracts (entered into in the ordinary course of business or consistent with past practice)),

$_____

(xix)cash expenses relating to earn outs and similar obligations,

$_____

(xx)costs incurred prior to the Closing Date associated with the initial public offering of Holdings of its common Equity Interests pursuant to the prospectus dated August 10, 2016,

$_____

(xxi)costs incurred prior in connection with any secondary public offering and/or new registrations of Holdings or its Equity Interests, and

$_____

(xxii)any loss relating to Swap Contracts (excluding Swap Contracts entered into in the ordinary course of business or consistent with past practice);

$_____

2.1Total

$_____

Minus

 

 

 

Schedule 2-4

 

 

84402209_5